Shandong Bainuo Pharmaceutical DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

VectorY Bets $1.2 B+ on Shape's Brain-Penetrant Capsids

19 Sep 2025

// BIOSPACE

Roche Becomes MASH Player via $3.5 B Deal for 89bio, Ph. 3 Drug

19 Sep 2025

// GLOBENEWSWIRE

Biogen Inks $85 M Alcyone Buyout to Acquire Drug Delivery Tech

19 Sep 2025

// FIERCE BIOTECH

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

World Drug Safety EU

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content

radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Shandong Bainuo Pharmaceutical Co., Ltd. was established in August 2000 and is headquartered in Jinan City, Shandong Province. It is committed to building a leading pharmaceutical R&D technology platform company in China. It has passed the ISO9001 international quality management system and intellectual property management system certification, and established the "R&D Industry " Academician Workstation" , the vice-chairman unit of the Pharmaceutical Research and Development Branch of the All-China Federation of Industry and Commerce, and obtained the "Drug Production License" of the first research institution in Shandong Province.